1. 525 SURGICAL MORBIDITY AND MORTALITY FROM THE NEORESII TRIAL: STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER. (14th September 2020) Authors: Nilsson, K; Klevebro, F; Rouvelas, I; Lindblad, M; Szabo, E; Halldestam, I; Smedh, U; Wallner, B; Johansson, J; Johnsen, G; Kjus Ahlin, E; Johannessen, H; Hjortland, G; Bartella, I; Schröder, W; Bruns, C; Nilsson, M Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ESRA19-0388 Fentanyl sublingual is not inferior to fentanyl intravenous for acute trauma pain – a prospective, gender-comparing, randomized, double-blind, clinical, single-center noninferiority trial. (30th August 2019) Authors: Gruber, E; Oberhammer, R; Dal Cappello, T; Wallner, B; Brugger, H; Strapazzon, G Journal: Regional anesthesia and pain medicine Issue: Volume 44(2019)Supplement 1 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O148 SHORT-TERM RESULTS OF A RANDOMIZED CONTROLLED TRIAL OF STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIATION FOR CANCER. (23rd November 2019) Authors: Nilsson, K; Klevebro, F; Szabo, E; Halldestam, I; Johnsson, E; Wallner, B; Johansson, J; Johnsen, G; Aahlin, E K; Hjortland, G O; Bruns, C; Schröder, W; Nilsson, M Journal: Diseases of the esophagus Issue: Volume 32(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗